Your browser doesn't support javascript.
loading
Diabetes and factors associated with cognitive and functional decline. The screening for CKD among older people across Europe (SCOPE) study.
Formiga, Francesc; Badía-Tejero, Ana María; Corsonello, Andrea; Ärnlöv, Johan; Carlsson, Axel C; Mattace-Raso, Francesco; Tap, Lisanne; Kostka, Tomasz; Guligowska, Agnieszka; Sieber, Cornel C; Kob, Robert; Ben-Romano, Ronit; Yehoshua, Ilan; Roller-Wirnsberger, Regina; Wirnsberger, Gerhard H; Fabbietti, Paolo; Lattanzio, Fabrizia; Moreno-González, Rafael.
Affiliation
  • Formiga F; Geriatric Unit, Internal Medicine Department, Systemic Diseases and Ageing Group, Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Badía-Tejero AM; Geriatric Unit, Internal Medicine Department, Systemic Diseases and Ageing Group, Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Corsonello A; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy.
  • Ärnlöv J; Center for Biostatistic and Applied Geriatric Clinical Epidemiology (IRCCS INRCA), National Institute of Health and Science on Ageing, Cosenza, Ancona, Italy.
  • Carlsson AC; Division of Family Medicine, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
  • Mattace-Raso F; School of Health and Social Studies, Dalarna University, Falun, Sweden.
  • Tap L; Division of Family Medicine, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
  • Kostka T; Academic Primary Health Care Centre, Region Stockholm, Stockholm, Sweden.
  • Guligowska A; Section of Geriatric Medicine, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Sieber CC; Section of Geriatric Medicine, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Kob R; Department of Geriatrics, Healthy Ageing Research Centre, Medical University of Lódz, Hallera 1, 90-647, Lódz, Poland.
  • Ben-Romano R; Department of Geriatrics, Healthy Ageing Research Centre, Medical University of Lódz, Hallera 1, 90-647, Lódz, Poland.
  • Yehoshua I; Institute for Biomedicine of Aging (IBA), Friedrich-Alexander-Universität Erlangen-Nürnberg, Nuremberg, Germany.
  • Roller-Wirnsberger R; Institute for Biomedicine of Aging (IBA), Friedrich-Alexander-Universität Erlangen-Nürnberg, Nuremberg, Germany.
  • Wirnsberger GH; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beersheba, Israel.
  • Fabbietti P; Maccabi Health Organization, Negev District, Beersheba, Israel.
  • Lattanzio F; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beersheba, Israel.
  • Moreno-González R; Maccabi Health Organization, Negev District, Beersheba, Israel.
Aging Clin Exp Res ; 35(11): 2693-2701, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37668841
ABSTRACT

BACKGROUND:

Type 2 diabetes mellitus (DM) in older people is a heterogeneous condition that exhibits differential characteristics in comparison with younger adults. DM increases the risk of disability, is associated with dementia and loss of function, and cognition may often be interrelated and more pronounced in older patients with DM than in those without.

AIMS:

Our aim was to evaluate the incidence of functional and/or cognitive impairment in older adults with and without DM, and its associated factors in DM participants.

METHODS:

A 2-year prospective analysis was conducted in a European multicenter prospective cohort (SCOPE study). Older community-dwelling adults (aged ≥ 75 years) underwent a comprehensive geriatric assessment. New functional and/or cognitive decline was explored.

RESULTS:

Of 1611 participants, 335 (22.0%) had DM at baseline. The percentage of participants scoring at least one ADL impairment and/or cognitive impairment (MMSE < 24) was similar in both groups (9.6%). Factors associated with any new disability in participants with DM in the multivariate analysis were female sex (OR 3.28, 95% CI 1.42-7.56), history of stroke (OR 4.58, 95% CI 1.64-12.7), and greater IADL dependency (OR 1.08 95% CI 1.02-1.15).

DISCUSSION:

Association between DM and cognitive or functional decline in outpatients of 75 years and older was not found, but factors such as female gender, history of stroke, and IADL dependency could be related.

CONCLUSION:

Decline in functional and cognitive status of community-dwelling older adults with DM was similar to participants without DM in a short period of 2 years of follow-up, though several clinical factors may increase its risk in this population.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stroke / Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies / Screening_studies Limits: Aged / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Aging Clin Exp Res Journal subject: GERIATRIA Year: 2023 Type: Article Affiliation country: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stroke / Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies / Screening_studies Limits: Aged / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Aging Clin Exp Res Journal subject: GERIATRIA Year: 2023 Type: Article Affiliation country: Spain